Gastrin Antibody (GAST/2634) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-08696IR
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Immunohistochemistry-Paraffin
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # GAST/2634
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Gastrin Antibody (GAST/2634) [DyLight 755]
Immunogen
Recombinant full-length human Gastrin protein (Uniprot: P01350)
Localization
Secreted.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for Gastrin Antibody (GAST/2634) [DyLight 755]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Gastrin I
Alternate Names
G17, GAST, Gastrin-17
Gene Symbol
GAST
Additional Gastrin I Products
Product Documents for Gastrin Antibody (GAST/2634) [DyLight 755]
Product Specific Notices for Gastrin Antibody (GAST/2634) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...